Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

The role of inhaled and/or nasal corticosteroids on the bronchodilator response

  • Lee, Ju-Kyung (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Suh, Dong-In (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Koh, Young-Yull (Department of Pediatrics, Seoul National University College of Medicine)
  • 투고 : 2010.08.13
  • 심사 : 2010.10.16
  • 발행 : 2010.11.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: To compare the profiles of the bronchodilator response (BDR) among children with asthma and/or allergic rhinitis (AR) and to determine whether BDR in these children is reduced by treatment with inhaled and/or nasal corticosteroid. Methods: Sixty-eight children with asthma (mean age, 10.9 years), 45 children with comorbid asthma and AR (mean age, 10.5 years), and 44 children with AR alone (mean age, 10.2 years) were investigated. After a 2-week baseline period, all children were treated with inhaled fluticasone propionate (either 100 or $250{\mu}g$ b.i.d., tailored to asthma severity) or nasal fluticasone propionate (one spray b.i.d. in each nostril) or both, according to the condition. Before and 2 weeks after starting treatment, all children were evaluated with spirometry and bronchodilator testing. BDR was calculated as a percent change from the forced expiratory volume in 1 second ($FEV_1$) at baseline. Results: The mean BDR was 10.3% [95% confidence interval (CI) 8.3-12.4%] in children with asthma, 9.0% (95% CI 7.3-10.9%) in subjects with asthma and AR, and 5.0% (95% CI 4.1-5.9%) in children with AR alone ($P$<0.001). After treatment, the mean BDR was reduced to 5.2% (95% CI 4.2-6.3%) ($P$<0.001) in children with asthma and to 4.5% (95% CI 3.5-5.5%) ($P$<0.001) in children with asthma and AR. However, children with rhinitis showed no significant change in BDR after treatment, with the mean value being 4.7% (95% CI 3.7-5.8%) ($P$=0.597). Conclusion: The findings of this study imply that an elevated BDR in children with AR cannot be attributed to nasal inflammation alone and highlights the close relationship between the upper and lower airways.

키워드

참고문헌

  1. Corren J. Allergic rhinitis and asthma: How important is the link? J Allergy Clin Immunol 1997;99:S781-6. https://doi.org/10.1016/S0091-6749(97)70127-1
  2. Togias A. Rhinitis and asthma: Evidance for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-83. https://doi.org/10.1067/mai.2003.1592
  3. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58:691-706. https://doi.org/10.1034/j.1398-9995.2003.00105.x
  4. Blair H. Natural history of childhood asthma: 20-year follow-up. Arch Dis Child 1977;52:613-9. https://doi.org/10.1136/adc.52.8.613
  5. Alvarez MJ, Olaguibel JM, Garcia BE, Rodriguez A, Tabar AI, Urobiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000;55:355-62. https://doi.org/10.1034/j.1398-9995.2000.00312.x
  6. Koh YY, Kim CK. The development of asthma in patients with allergic rhinitis. Curr Opin Allergy Clin Immunol 2003;3:159-64. https://doi.org/10.1097/00130832-200306000-00002
  7. Reed CE, Marcoux JP, Welsh PW. Effects of topical treatment on asthma symptoms. J Allergy Clin Immunol 1988;81:1042-7. https://doi.org/10.1016/0091-6749(88)90177-7
  8. Ulrik CS, Postma D, Backer V. Recognition of asthma in adolescents and young adults: Which objective measure is best? J Asthma 2005;42:549-54. https://doi.org/10.1080/02770900500215715
  9. Koga T, Kamimura T, Oshita Y, Narita Y, Mukaino T, Nishimura M, et al. Determinants of bronchodilator responsiveness in patients with controlled asthma. J Asthma 2006;43:71-4. https://doi.org/10.1080/02770900500448662
  10. Dundas I, Chan EY, Bridge PD, Mckenzie SA. Diagnostic accuracy of bronchodilator responsiveness in wheezy children. Thorax 2005;60:13-6. https://doi.org/10.1136/thx.2004.029934
  11. Kumar R, Wang B, Wang X, Chen C, Yang J, Fu L, et al. Bronchodilator responses in Chinese children from asthma index families and the general population. J Allergy Clin Immunol 2006;117:1257-63. https://doi.org/10.1016/j.jaci.2006.02.049
  12. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC, et al. Bronchodilation and bronchoconstriction: Predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006;117:1264-71. https://doi.org/10.1016/j.jaci.2006.01.050
  13. Ciprandi G, Cirillo I, Pistorio A, La Grutta S, Tosca M. Impact of allergic rhinitis on asthma: effects on bronchodilation testing. Ann Allergy Asthma Immunol 2008;101:42-6. https://doi.org/10.1016/S1081-1206(10)60833-2
  14. Suh DI, Lee JK, Lee JH, Koh YY. Bronchodilator response and its relationship to bronchial hyperresponsiveness in children with allergic rhinitis/asthma. Pediatr Allergy Respir Dis(Korea) 2010;20:59-67.
  15. Morris HG. Mechanisms of action and therapeutic role of corticosteroids in asthma. J Allergy Clin Immunol 1985;75:1-13. https://doi.org/10.1016/0091-6749(85)90002-8
  16. Kerstjens HA, Brand PL, Quanjer PH, van der Bruggen-Bogaarts BA, Koeter GH, Postma DS. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airway disease. Dutch CNSLD Study Group. Thorax 1993;48:722-9. https://doi.org/10.1136/thx.48.7.722
  17. Faul JL, Demers EA, Burke CM, Poulter LW. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest 2002;121:1414-20. https://doi.org/10.1378/chest.121.5.1414
  18. Mygind N. Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996;26:2-10.
  19. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-36. https://doi.org/10.1164/ajrccm.152.3.7663792
  20. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S, Barreto ML, et al. Lack of control of severe asthma is associated with coexistence of moderate-to-severe rhinitis. Allergy 2008;63:564-9. https://doi.org/10.1111/j.1398-9995.2007.01624.x
  21. Jang AS, Park JS, Lee JH, Park SW, Kim DJ, Uh ST, et al. Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis. Allergy Asthma Immunol Res 2010;2:108-13. https://doi.org/10.4168/aair.2010.2.2.108
  22. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18. https://doi.org/10.1164/ajrccm/144.5.1202
  23. Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naive asthmatic children. J Pediatr 2007;151:457-62. https://doi.org/10.1016/j.jpeds.2007.05.004
  24. Capasso M, Varricchio A, Ciprandi G. Impact of allergic rhinitis on asthma in children: effects on bronchodilation test. Allergy 2010;65:264-8. https://doi.org/10.1111/j.1398-9995.2009.02168.x
  25. Lipworth BJ, Clark RA, Dhillon DP, Brown RA, McDevitt DG. B-adrenoreceptor response to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol 1988;26:527-33. https://doi.org/10.1111/j.1365-2125.1988.tb05292.x
  26. Covar RA, Szefler SJ, Martin RJ, Sundstrim DA, Silkoff PE, Murphy J, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003;142:469-75. https://doi.org/10.1067/mpd.2003.187
  27. Colon-Semidey AJ, Marshik P, Crowley M, Katz R, Kelly HW. Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatr Pulmonol 2000;30:385-92. https://doi.org/10.1002/1099-0496(200011)30:5<385::AID-PPUL4>3.0.CO;2-#
  28. Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997;27:1138-44. https://doi.org/10.1111/j.1365-2222.1997.tb01150.x
  29. Faul JL, Leonard CT, Burke CM, Tormey VJ, Poulter LW. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time. Thorax 1998;53:753-61. https://doi.org/10.1136/thx.53.9.753
  30. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8. https://doi.org/10.1067/mai.2002.122635
  31. Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P. Intranasal corticosteroid administration reduces nonspecific bronchial hyper-responsiveness and improves asthma symptoms. J Asthma 2008;45:754-7. https://doi.org/10.1080/02770900802249149
  32. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma symptoms. J Allergy Clin Immunol 1988;81:1042-7. https://doi.org/10.1016/0091-6749(88)90177-7
  33. Mygind N, Dahl R, Nielsen LP. Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma. Respir Med 1998;92:547-9. https://doi.org/10.1016/S0954-6111(98)90306-7
  34. Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, et al. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005;128:1910-20. https://doi.org/10.1378/chest.128.4.1910
  35. Nair A, Vaidyanathan S, Clearie K, Williamson P, Meldrum K, Lipworth BJ. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. Allergy 2010;65:359-67. https://doi.org/10.1111/j.1398-9995.2009.02187.x
  36. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:313-20. https://doi.org/10.1067/mai.2003.64
  37. Kessel A, Halloun H, Bamberger E, Kugelman A, Toubi E. Abnormal spirometry in children with persistent allergic rhinitis due to mite sensitization: The benefit of nasal corticosteroids. Pediatr Allergy Immunol 2008;19:61-6.
  38. Ciprandi G, Cririllo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 2006;118:1105-9. https://doi.org/10.1016/j.jaci.2006.05.010
  39. Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, et al. An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol 2010;45:174-81. https://doi.org/10.1002/ppul.21172
  40. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001;31:61-8. https://doi.org/10.1111/j.1365-2222.2001.00964.x

피인용 문헌

  1. Research on pediatric allergic rhinitis in Korea vol.6, pp.suppl1, 2010, https://doi.org/10.4168/aard.2018.6.s1.s58